The abnormal accumulation of activated Lyn kinase caused by chorein protein deficiency has been proven to be responsible for part of pathological phenotypes of ChAc, and it is a potential therapeutic target to treat ChAc. Here, VPS13A is linked to chorea-acanthocytosis.